Clinical trial
Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes
NCT00108303 · VA Office of Research and Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00108303 |
|---|---|
| Title | Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes |
| Official title | Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes in Individuals Extensively Diagnosed and Genotyped |
| Lead sponsor | VA Office of Research and Development, U.S. Fed |
| Status | Completed |
| Study type | Observational |
| Conditions | Schizophrenia |
| Intervention type | Other |
| Interventions | Diagnostic |
| Enrollment | 538 |
| Start date | Jan 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Apr 15, 2005 |
| Last update posted | Jan 7, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: